From: Update on the pathogenic potential and treatment options for Blastocystis sp
Treatment (Dose) | Efficacy | Reference |
---|---|---|
Iodoquinole (650 mg t.i.d) | 0% | [91] |
Emetine (100 μg/ml) | 50% | [92] |
Metronidazole (2000 mg s.i.d) | 0% | [93] |
Metronidazole (1500 mg s.i.d) | 100% | [26] |
Metronidazole (750 mg t.i.d) | 100% | [24] |
Metronidazole (750 mg t.i.d) | 100% | [21] |
Metronidazole (500 mg t.i.d) | 100% | [79] |
Metronidazole (250- 750 mg t.i.d) | 33% | [80] |
Metronidazole (750 mg t.i.d) | 100% | [81] |
Metronidazole (1500 mg s.i.d) | 80% | [94] |
Metronidazole (800 mg t.i.d) | 0% | [30] |
Metronidazole (30 mg/kg twice daily) | 67% | [89] |
Nitazoxanide (500 mg t.i.d) | 100% | [86] |
Nitazoxanide (100-200Â mg b.i.d for children <12Â yr, 500Â mg b.i.d for >11Â yr) | 86% | [88] |
Nitazoxanide (500 mg t.i.d) | 100% | [95] |
Ornidazole (500 mg t.i.d) | 50% | [96] |
Paromomycin (25 mg/kg t.i.d) | 100% | [93] |
Paromomycin (500 mg t.i.d) | 100% | [97] |
Paromomycin (25 mg/kg t.i.d) | 100% | [82] |
Paromomycin (1000 mg b.i.d) & MZ (750 mg t.i.d) | 100% | [25] |
Saccharomyces boulardii (250Â mg b.i.d) | 78% | [89] |
Trimethroprim-SMX | 22% | [80] |
Trimethroprim-SMX (6Â mg/kg TMP, 30Â mg/kg SMX s.i.d) | 95% | [98] |
Trimethropim- SMX (320Â mg TMP, 1600Â mg SMX s.i.d) | 93% | [98] |
Trimethroprim- SMX (80Â mg TMP, 400Â mg SMX t.i.d) | 100% | [30] |
Triple therapy (nitazoxanide, furazolidone and secnidazole) | 0% | [90] |